Company Overview and News

9
New Residential Investment: Strong Buy On The Drop

2018-10-14 seekingalpha
New Residential Investment Corp. (NRZ) is a "Strong Buy" on the drop for investors with a contrarian bent and a high risk-tolerance. New Residential Investment Corp. is a high-quality income vehicle with a diversified investment portfolio and significant interest rate upside in a rising rate environment. The mortgage REIT easily out-earns its dividend with core earnings, and is in a good position to hand shareholders another dividend raise.
NRZ

29
AGNC Investment's Q3 2018 Income Statement And Earnings Preview - Part 3 (Notable MBS Price Decreases)

2018-10-10 seekingalpha
I am projecting AGNC will report a combined notable net unrealized loss on available-for-sale securities and investment securities measured at FMV for the third quarter of 2018.
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW WMC NRZ AIC CYS TRI MTGE MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC HTS IVR NYMT FMCCS FMCCT

13
AGNC Investment's Q3 2018 Income Statement And Earnings Projection - Part 2 (Hedges Partially To The Rescue)

2018-10-09 seekingalpha
Fairly similar to the prior quarter, I am projecting AGNC will report a modest-notable gain regarding the company’s derivative instruments and other securities for the third quarter of 2018.
NYMTO ORC CHMI NYMTP AI TWO AGNC AIW NRZ AIC NLY CYS ARR NYMT

12
Top 50 Russell Stocks Yield 7.4% To 17.5% In October

2018-10-05 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
NYMTO ORC STWD.WI MITT NYMTP CIM GMRE AGNC WMC AJXA GOV PEGI NRZ DX GOVNI VGR SIR PEG NYMT STWD AJX

26
Ocwen Financial Completes Acquisition of PHH Corporation; Glen Messina Becomes President and Chief Executive Officer

2018-10-04 globenewswire
WEST PALM BEACH, Fla., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation (NYSE:OCN) (“Ocwen” or the “Company”), a leading financial services holding company, today announced the completion of its acquisition of PHH Corporation (“PHH”), a mortgage platform with established servicing and origination recapture capabilities, effective October 4, 2018 for approximately $360 million in cash or $11 per diluted common share.
DTK OCN FNMA FMCKI FMCKJ FREGP FMCCO FMCCP FMCCM FMCCN FMCCK NRZ FMCCL FMCCI FMCCJ FMCCG FMCKO FMCCH FMCKP FMCKM FMCKN FMCKK FMCKL FREJN FREJO FREJP FMCC PHH FMCCS FMCCT

13
AGNC Investment's Q3 2018 Income Statement And Earnings Projection - Part 1 (Including Net Spread Trend)

2018-10-03 seekingalpha
This series projects AGNC’s income statement for the third quarter of 2018. These projections help readers understand how most of the fixed-rate agency mREIT sector performed (valuable insight).
NYMTO ORC CHMI NYMTP AI AGNC AIW MO NRZ AIC NLY CYS ARR HTS NYMT

17
Wall Street Targets 90 Champions, Contenders, And Challengers As Dividend Stars For October

2018-10-03 seekingalpha
Champion dividend stocks sustain 25 or more annual dividend increases; Contenders show 10-24, Challengers have 5-9. WallStar selections all show .05% or higher price target upsides.
ENBBF NYSE PEGI TLP HMLP NRZ ENB EPD MDP SEP SRLP ENB EQM VGR PBFX SIR APU MDPEB SUN PEG EBBNF

16
Annaly Capital's Dividend And Valuation Compared To 19 mREIT Peers (Includes Q4 2018 And 2019 Dividend Projections) - Part 2

2018-09-24 seekingalpha - 1
This article compares NLY’s recent dividend per share rates, yield percentages, and several dividend sustainability metrics to 19 mREIT peers.
ANH NYMTO ORC CHMI NYMTP AI CIM CMO TWO AGNC AIW GPMT MO WMC NRZ AIC CYS 511505 CAPITALT MITT MFO DX NLY ARR BXMT MFA IVR NYMT

9
New Residential Investment: Why Not Buy This Top-Shelf 11.1%-Yielding Mortgage REIT?

2018-09-21 seekingalpha
New Residential Investment Corp. (NRZ) remains a "Strong Buy" for income investors with an above-average risk tolerance. The mortgage REIT has considerable interest rate upside in a rising rate environment, and is a strong income vehicle as far as dividend coverage is concerned. New Residential Investment Corp. consistently outearned its dividend with core earnings in the last three years, and shares sell for a sensible core earnings-multiple.
NRZ

12
Top 50 Real Estate WallStars Show Yields To 15.26% And Net Gains To 131.29% By September 2019

2018-09-21 seekingalpha
WallStars show positive broker target price upsides. IRSA Propiedades flaunted top net gains, while Government Properties showed the highest yield.
GEO ORC ASHFP CHMI CYORP CIM AHT.WI TWO AGNC CIO AJXA GOV NRZ MFO GLPI GOVNI MFA SIR AJX AHT

29
AGNC Investment And Orchid Island Capital: MBS Pricing For Q3 2018 (Recent Cautionary Trend)

2018-09-20 seekingalpha
Following continued requests by readers, this article analyzes fixed-rate agency MBS price movements during the third quarter of 2018 (through 9/14/2018).
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS TRI MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC IVR NYMT FMCCS FMCCT

14
32
This Giant 20% Yield Is Ripe For The Picking

2018-09-03 seekingalpha - 1
This ETN yields 20% based on recent prices. Investors are set to double their initial investment in less than 5 years.
CS STWD.WI FNMA FMCKI FMCKJ ABRN REM LADR TWO AGNC ABR FMCCO FMCCP FMCCM FMCCN NRZ FMCCI NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK CYS FMCKL FMCC ABRN.CL STWD FMCCS FMCCT

13
50 Russell Index Stocks Yield 5.7% To 12% For August

2018-08-28 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
GEO LB ORC STWD.WI ASHFP AHT.WI TWO TUP OUT AJXA KDP NRZ DX SFL VGR SIR GNL JCAP STWD AJX AHT

15
Brokers Tag 90 Champions, Contenders, And Challengers As Wall St. Dividend Stars For August

2018-08-27 seekingalpha
Champion dividend stocks sustain 25 or more annual dividend increases; Contenders show 10-24; Challengers have 5-9. WallStar selections all show .05% or higher price target upsides.
TLP HMLP NRZ EPD MDP BPL SRLP ETP VGR SIR CVX DKL WES APU MDPEB SUN

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to NRZ / New Residential Investment Corp. on message board site Silicon Investor.

SNRZ Sunrise Assited Living, Inc SNRZ Sunrise Assited Living, Inc SNRZ Sunrise Assited Living, Inc
CUSIP: 64828T201